Sarepta Therapeutics Director Sells Shares
Claude Nicaise, a Director at Sarepta Therapeutics, sold 2,491 shares of Common Stock on March 12, 2025, at a weighted average price of $99.64 per share, totaling $248,203. Following the transaction, Nicaise directly owns 27,812 shares of the company. The sale was conducted to cover the exercise price of stock options expiring in 2025.
SEC Filing:
Sarepta Therapeutics, Inc. [ SRPT ] - Form 4 - Mar. 13, 2025
Reporter Name
Nicaise Claude
Relationship
Director
Type
Sell
Amount
$248,203
SEC Filing
Form 4